IJMS, Vol. 24, Pages 5805: The Central Noradrenergic System in Neurodevelopmental Disorders: Merging Experimental and Clinical Evidence

IJMS, Vol. 24, Pages 5805: The Central Noradrenergic System in Neurodevelopmental Disorders: Merging Experimental and Clinical Evidence

International Journal of Molecular Sciences doi: 10.3390/ijms24065805

Authors: Alessandro Galgani Emanuele Bartolini Marta D’Amora Ugo Faraguna Filippo Sean Giorgi

The aim of this article is to highlight the potential role of the locus-coeruleus–noradrenergic (LC-NA) system in neurodevelopmental disorders (NdDs). The LC is the main brain noradrenergic nucleus, key in the regulation of arousal, attention, and stress response, and its early maturation and sensitivity to perinatal damage make it an interesting target for translational research. Clinical data shows the involvement of the LC-NA system in several NdDs, suggesting a pathogenetic role in the development of such disorders. In this context, a new neuroimaging tool, LC Magnetic Resonance Imaging (MRI), has been developed to visualize the LC in vivo and assess its integrity, which could be a valuable tool for exploring morphological alterations in NdD in vivo in humans. New animal models may be used to test the contribution of the LC-NA system to the pathogenic pathways of NdD and to evaluate the efficacy of NA-targeting drugs. In this narrative review, we provide an overview of how the LC-NA system may represent a common pathophysiological and pathogenic mechanism in NdD and a reliable target for symptomatic and disease-modifying drugs. Further research is needed to fully understand the interplay between the LC-NA system and NdD.